Main Article Content

Abstract

Psychotic disorders, including schizophrenia, significantly impact individuals' mental health, necessitating innovative therapeutic approaches. This study evaluates the antipsychotic potential of ethanolic extracts of Mentha arvensis L. leaves through apomorphine-induced psychosis in rats. The extract's phytochemical profile revealed the presence of alkaloids, flavonoids, and phenols, among others, indicating its bioactive potential. In vitro antioxidant assays demonstrated notable nitric oxide and superoxide anion scavenging activities, suggesting its neuroprotective properties. Behavioral studies, including the pole climbing and catatonic tests, highlighted significant improvements in motor coordination and reduced catatonic symptoms with the extract, especially at 200 mg/kg. Biochemical analyses indicated a restorative effect on dopamine levels and modulation of monoamine oxidase (MAO-A and MAO-B) activities, reflecting its potential mechanisms of antipsychotic action. These findings align with traditional medicinal uses of Mentha arvensis for mental health. The results underscore the therapeutic promise of Mentha arvensis in managing psychosis, with implications for its use as a natural adjunctive treatment. Further research is needed to isolate active compounds, understand molecular mechanisms, and assess safety and efficacy in clinical settings. This study highlights the integration of phytochemical and pharmacological approaches to uncover novel antipsychotic agents.

Keywords

Mentha arvensis psychosis antipsychotic activity dopamine modulation oxidative stress

Article Details

How to Cite
R. Krishnan, & G. Muthukumaran. (2025). Evaluation Of Anti-Psychotic Effect Of Mentha Arvensis L Leaves In Apomorphine Induced Psychosis In Rats. International Journal of Research in Pharmacology & Pharmacotherapeutics, 14(1), 42-53. Retrieved from https://ijrpp.com/ijrpp/article/view/614

References

  1. 1. Steiner J. Psychic retreats: Pathological organizations in psychotic, neurotic and borderline patients. Routledge; 2003 Sep 2.
  2. 2. Algon S, Yi J, Calkins ME, Kohler C, Borgmann-Winter KE. Evaluation and treatment of children and adolescents with psychotic symptoms. Current psychiatry reports. 2012 Apr;14:101-10.
  3. 3. McCutcheon RA, Marques TR, Howes OD. Schizophrenia—an overview. JAMA psychiatry. 2020 Feb 1;77(2):201-10.
  4. 4. Holtzman CW, Trotman HD, Goulding SM, Ryan AT, Macdonald AN, Shapiro DI, Brasfield JL, Walker EF. Stress and neurodevelopmental processes in the emergence of psychosis. Neuroscience. 2013 Sep 26;249:172-91.
  5. 5. Thawkar BS. Phytochemical and pharmacological review of Mentha arvensis. International Journal of Green Pharmacy (IJGP). 2016 Jun 27;10(2).
  6. 6. Thakur S, Walia B, Chaudhary G. Mentha arvensis (Pudina): A review based upon its medicinal properties. Research journal of Pharmacognosy and Phytochemistry. 2021;13(3):143-8.
  7. 7. Biswas NN, Saha S, Ali MK. Antioxidant, antimicrobial, cytotoxic and analgesic activities of ethanolic extract of Mentha arvensis L. Asian Pacific Journal of Tropical Biomedicine. 2014 Oct 1;4(10):792-7.
  8. 8. Akbari B, Baghaei‐Yazdi N, Bahmaie M, Mahdavi Abhari F. The role of plant‐derived natural antioxidants in reduction of oxidative stress. BioFactors. 2022 May;48(3):611-33.
  9. 9. Liu F, Ooi VE, Chang ST. Free radical scavenging activities of mushroom polysaccharide extracts. Life sciences. 1997 Jan 31;60(10):763-71.
  10. 10. Singh RK, GAUTAM RK, Karchuli MS. Evaluation of nephroprotective activity of Mentha arvensis l. in cisplatin induced nephrotoxicity. Asian journal of Pharmaceutical and clinical research. 2014;7(4).
  11. 11. Khan SS, Khatik GL, Datusalia AK. Strategies for Treatment of Disease-Associated Dementia Beyond Alzheimer's Disease: An Update. Current Neuropharmacology. 2023 Feb 1;21(2):309-39.
  12. 12. Muench J, Hamer AM. Adverse effects of antipsychotic medications. American family physician. 2010 Mar 1;81(5):617-22.
  13. 13. Hupparage VB, Rasal VP, Patil VS, Patil PP, Mulange SG, Malgi AP, Patil SA, Karade AR. Ameliorative effect of Amaranthus tricolor L. leaves on scopolamine-induced cognitive dysfunction and oxidative stress in rats. Journal of Applied Pharmaceutical Science. 2020 Oct 5;10(10):111-20.
  14. 14. Baboota S, Ali J. Combination antipsychotics therapy for schizophrenia and related psychotic disorders interventions: Emergence to nanotechnology and herbal drugs. Journal of Drug Delivery Science and Technology. 2021 Feb 1;61:102272.
  15. 15. Miller R. Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part II. Current Neuropharmacology. 2009 Dec 1;7(4):315-30.